Effects of Increasing Metformin Dose vs Adding/Switching to Dipeptidyl Peptidase-4 Inhibitors on Glycemic Control in Patients With Type 2 Diabetes

media

posted on 2021-02-15, 10:44 authored by Adis journals on behalf of, Yoshio Nagai, Kiyoyasu Kazumori, Tomomi Takeshima, Kosuke Iwasaki, Yasushi Tanaka

Article full text

The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

History

Usage metrics

Keywords

Claims database Combination drug therapy Dipeptidyl peptidase-4 inhibitors Dose increased Drug switch Glycated hemoglobin A Glycemic control Hypoglycemic agents Metformin Type 2 diabetes

Licence

CC BY-NC 4.0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM